CD8A and neoplasm: Likewise, patients were divided into two groups according to CD8+ TIL density in the recurrent tumor, PD-L1 density in the initial tumor, and PD-L1 density in the recurrent tumor, based on each median value (107.1/μm2, 86,576.7/μm2, and 50,173.3/μm2, respectively).